Form 4: Credo Technology CTO Sells $8.27M in Shares
Insider Transaction Report
Credo Technology Group Holding Ltd's CTO, Cheng Chi Fung, sold 50,000 ordinary shares for approximately $8.27 million through a Rule 10b5-1 trading plan.
Summary
- Cheng Chi Fung, Director and Chief Technology Officer of Credo Technology Group Holding Ltd (CRDO), reported the sale of ordinary shares.
- A total of 50,000 ordinary shares were sold on October 20, 2025.
- The sales were executed in multiple trades at weighted average prices ranging from $148.1547 to $153.68 per share.
- The transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted by the Cheng Huang Family Trust on September 6, 2024.
- Following these transactions, the Cheng Huang Family Trust beneficially owns 6,723,961 ordinary shares.
- The total value of the shares sold is approximately $8,269,281.75.
Sentiment
Score: 3
Explanation: The sale of a significant number of shares by a high-ranking insider, even under a 10b5-1 plan, typically generates negative sentiment as it can be perceived as a lack of confidence or a belief that the stock is fully valued.
Positives
- The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned divestment rather than an immediate reaction to new, undisclosed information.
Negatives
- A significant insider sale by a key executive (CTO and Director) could be perceived negatively by the market.
- The total value of shares sold is substantial, approximately $8.27 million.
Risks
- Insider selling, especially by a high-ranking executive, can sometimes signal a lack of confidence in the company's near-term prospects, potentially leading to negative investor sentiment.
- The market might interpret the sale as a signal that the stock price may be nearing a peak or that future growth opportunities are limited.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Adoption | The sales were executed pursuant to a Rule 10b5-1 trading plan adopted by the Cheng Huang Family Trust. | 09/06/2024 | A Rule 10b5-1 plan provides an affirmative defense against insider trading allegations, indicating pre-planned sales rather than opportunistic trading based on material non-public information. |
Related Party Transactions
- The shares were held and sold by the Cheng Huang Family Trust, of which the Reporting Person (Cheng Chi Fung) and his spouse are trustees, and the Reporting Person, his spouse, and their children are beneficiaries.
Stakeholder Impact
- Shareholders: May interpret the insider sale as a negative signal, potentially leading to downward pressure on the stock price or reduced investor confidence.
Key Dates
| Date | Description |
|---|---|
| 09/06/2024 | Date the Rule 10b5-1 trading plan was adopted by the Cheng Huang Family Trust. |
| 10/20/2025 | Date of the reported share sales transactions. |
| 10/22/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThe significant sale of shares by a key executive, even under a pre-arranged Rule 10b5-1 plan, typically creates a cautious sentiment. While the plan indicates a scheduled divestment rather than an immediate reaction to adverse news, such a large insider sale by a Director and CTO can still be interpreted by the market as a signal that the stock may be fully valued or that the insider is diversifying their holdings. This warrants a 'hold' recommendation, suggesting investors monitor future company performance and insider activity closely before making further investment decisions.
Keywords
Credo Technology Group Holding Ltd, CRDO, Insider Trading, Form 4, Cheng Chi Fung, Share Sale, CTO, Director, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.